Respiratory Care Devices Global Market

–Forecast to 2026

Respiratory Care Devices Global Market estimated to be worth $23.5 billion by

2026

IQ4I Research & Consultancy published a new report on “Respiratory Care Devices
Global Market – Forecast To 2026” This report analyzes and studies the overall market,
major drivers & Opportunities, Restraints & Threats in North America, Europe, Asia-Pacific
and Rest of the World

IQ4I’s Report Contains 243 market data tables and 157 figures spread through 688
pages and an exhaustive TOC on “Respiratory Care Devices Global
Market [PRODUCTS (Diagnostic devices (Spirometer (volumetric & flow measuring), peak
flow meter, polysomnographs (Clinical & ambulatory), Therapeutic devices (Humidfiers
(active & passive), Nebulizer (jet, ultrasonic, mesh, & smart), Oxygen concentrators
(stationary & portable), PAP devices (APAP, BPAP, & CPAP), Resuscitators (manual & gas
powered), Ventilators (non-invasive & invasive), Inhalers (dry powder, metered dose &
soft mist), Others), Monitoring (Pulse oximeters (finger pulse, handheld, wrist pulse, &
tabletop), Capnographs, Gas analyzers), Consumables (Masks (nasal, full face, nasal pillow
& nasal oral), Tracheostomy tubes, Nasal Cannula); APPLICATION (Obstructive conditions
(COPD, Asthma, Cystic fibrosis, Obstructive Sleep Apnea), Restrictive Condition (ARDS,
Lung Cancer, Restricitve lung disease and Others), Vascular disease (Pulmonary fibrosis,
pulmonary edema, pulmonary hypertension) Infectious conditions (Pneumonia,
Tuberculosis); Others); REGIONAL (North America, Europe, Asia-Pacific and Rest of the
World)]
Respiratory care devices play a critical role in diagnosing, treating and monitoring respiratory
disorders. The respiratory devices include ventilators, PAP devices, inhalers, humidifiers,
nebulizers, oxygen concentrators, resuscitators, pulse oximeters, capnographs, spirometry,
and polysomnographs. These devices enhance and support respiratory system during life-
threatening and debilitating conditions such as pneumonia, asthma, bronchitis, sleep apnea,
cystic fibrosis, and pulmonary fibrosis, tuberculosis, COPD (Chronic Obstructive Pulmonary
Disease), etc. These conditions are increasing due to factors such as smoking, vehicular
emissions, air pollution, genetic issues, second-hand smoking, and presence of viral and
bacterial infections.

According to IQ4I analysis, the respiratory care devices global market is expected to grow at
high single digit CAGR from 2019 to 2026 to reach $23,510.9 million by 2026. Rising
incidences of respiratory diseases due to urbanization and air pollution, increasing
prevalence of tobacco usage, rising use of non-invasive respiratory care devices, growing
demand for home care respiratory devices, Advancements of technologies, a huge pool of
undiagnosed patients, and favourable reimbursement scenario, are driving the growth of the
respiratory care devices global market. Product recalls, harmful effects of certain devices on
neonates, availability of low-cost products from local manufacturers, stringent regulatory

IQ4I Research & Consultancy Pvt. Ltd. Page 1

Respiratory Care Devices Global Market

–Forecast to 2026

policies, and lack of awareness of the disease, are restraining the growth of Respiratory care
devices global market.

Among the respiratory care products, therapeutic devices commanded the largest market
share in 2019. The market is expected to grow at high single digit CAGR from 2019 to 2026.
In Respiratory care therapeutic devices, the ventilators commanded the largest market
share. PAP devices are expected to grow at double digit CAGR from 2019 to 2026. Among
applications, obstructive respiratory conditions commanded the largest market share in
2019. The market is expected grow at double digit CAGR from 2019 to 2026. In the end-user
market the hospitals segment commanded the largest share of the market in 2019. The
home care market is expected to grow at high single digit CAGR from 2019. Among the
hospital care sub-segments critical care/ICU segment commanded the largest revenue in
2019, the sleep center are expected to grow at a high single digit CAGR of from 2019 to
2026.

Some of the technological advancements in respiratory devices are integrated devices,

miniaturization, wireless technologies, wearable technologies, digital technologies, and
others. For instance, The cons of wired devices is immobile and has high maintenance
costs, making it unsuitable and unavailable in low resource settings has led to development
of wireless respiratory devices and it could overcome human resource challenges and
improve monitoring, particularly if alerts are inbuilt to detect abnormal values. Inogen is
focusing on a wireless platform named Inogen connect for oxygen concentrator
commercially for respiratory products. It is designed for the Inogen One G4 for its direct-to-
consumer channel. It has features that a front-end mobile application used by oxygen
therapy users and also has a back end-users portal for homecare providers.

The Respiratory care devices market is highly consolidated for ventilators and PAP devices,
whereas for other devices such as nebulizers, inhalers, humidifiers, pulse oximeters,
capnography, resuscitators, etc, and the market are fragmented. The respiratory devices
companies are involved in multiple mergers & acquisitions, expansions, deals, and
agreements. For instance, in March 2019, Resmed acquired HB healthcare (HBH) this
acquisition helps millions of South Koreans living with sleep apnea, chronic obstructive
pulmonary disease (COPD) and other respiratory conditions. HBH is a medical equipment
provider, serves both reimbursed and cash-pay customers of sleep and respiratory care
devices.

IQ4I Research & Consultancy Pvt. Ltd. Page 2

Respiratory Care Devices Global Market

–Forecast to 2026

Considering the attractiveness of respiratory care devices market, several venture

capitalists/investment banks are making strategic investments. For instance, in May 2019
European Investment Bank (EIB) funded Drager with $123.3 million for R&D projects on
medical technology targeting life saving system (ventilators). The efforts in medical systems
will centre on developing and enhancing patient monitoring products, with a special focus on
projects examining the connectivity of medical devices and linking them to hospitals’
information technology infrastructure. The global clinical trials focused on respiratory care
devices indicate that XX% of clinical trials are in phase 3, XX% clinical trials are in phase 2,
XX% clinical trials are in phase 1 and XX% clinical trials are in early phase 1. Majority of the
clinical trials are focused on respiratory insufficiency followed by respiratory distress
syndrome condition with Bi-level pressure ventilator followed by invasive mechanical
ventilator. There is steady increase in the number of clinical trials in coming years, which is
expected to drive the respiratory care devices market further.

In respiratory care devices global market by geography, the North America region held the
largest market share in 2019. The market is expected to grow at a high single digit CAGR
from 2019 to 2026 due to the availability of highly advanced healthcare facilities,
technological advancements, availability of Medicare and third-party insurance facilities,
easy availability of skilled personnel and Asia-Pacific region is expected to grow at high
single digit CAGR from 2019 to 2026 due to incorporating advanced technologies, growing
health awareness, and investments in the healthcare sector which creates new
opportunities.

Some of the major companies operating in the Respiratory care devices market area are
Dragerwerk AG & Co. KGaA (Germany), Fisher and Paykel Healthcare (New Zealand),
Inogen Inc., (U.S.), Medtronic PLC (Ireland), Philips N.V. (Netherlands), Resmed Inc (U.S.),
Vyaire Medical, Inc (U.S.), Getinge Group (Maquet Gmbh & Co. Kg) (Sweden), and GE
Healthcare (U.S.).

IQ4I Research & Consultancy Pvt. Ltd. Page 3

Respiratory Care Devices Global Market

–Forecast to 2026

Reasons for buying this report:

 Analysis of the respiratory care device global market by identifying various segments
by type, applications, end-users and geography.
 Revenue forecast of the respiratory care device market and strategic analysis of
each submarket with respect to segmental growth trends.
 Analysis of the major market trends and factors driving or inhibiting the growth of the
respiratory care device global market.
 Analysis of respiratory care devices market by major players, ventilators, PAP,
CPAP, APAP and BPAP devices.
 Region wise number of units sold for APAP, BPAP and CPAP devices.
 Revenue forecast of the respiratory care device market with respect to North
America, Europe, Asia-Pacific and the Rest of the World (RoW) regions.
 Analysis of the opportunities for stakeholders by identifying the high-growth
segments of the market.
 Market share analysis of key players in respiratory care device, details of their
product offerings, revenues, business strategies and SWOTs
 Established and Emerging players (110 companies) and their product offerings.

IQ4I Research & Consultancy Pvt. Ltd. Page 4

Respiratory Care Devices Global Market

–Forecast to 2026

FIGURE 1

RESPIRATORY CARE DEVICES GLOBAL MARKET SEGMENTATION

IQ4I Research & Consultancy Pvt. Ltd. Page 5